Medical marijuana commission alerts patients to how best to report negative reactions

An email from a medical marijuana dispensary owner alerting patients to a state investigation into whether a Maryland cannabis grower used pesticides and warning them of possible harmful side effects has spurred concern throughout the young industry.

The Maryland Medical Cannabis Commission took issue with the email in an online bulletin from executive director Joy A. Strand.

“The Commission is aware that a licensed dispensary issued a notification on July 22, 2018 recommending qualifying patients who experience an adverse event to processed products report the adverse event to that dispensary,” Strand wrote in the letter.

That notification was “not accurate,” Strand wrote.